HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chris Halpin Selected Research

Neuropilin-1

7/2009Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chris Halpin Research Topics

Disease

5Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2018 - 05/2009
5Acoustic Neuroma (Acoustic Neurinoma)
08/2012 - 08/2008
2Neoplasms (Cancer)
08/2012 - 07/2009
2Sensorineural Hearing Loss
08/2012 - 09/2003
1Tinnitus
01/2018
1Hearing Loss (Hearing Impairment)
01/2012
1Neurilemmoma (Schwannoma)
07/2009

Drug/Important Bio-Agent (IBA)

3Bevacizumab (Avastin)FDA Link
01/2018 - 07/2009
2SteroidsIBA
08/2012 - 09/2003
2Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2010 - 08/2008
1ParaffinIBA
07/2009
1Neuropilin-1IBA
07/2009
1Neuropilin-2IBA
07/2009
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2009
1Monoclonal AntibodiesIBA
07/2009
1Antineoplastic Agents (Antineoplastics)IBA
05/2009
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2003

Therapy/Procedure

2Hearing Aids (Hearing Aid)
01/2012 - 08/2008
1Aftercare (After-Treatment)
01/2018
1Therapeutics
08/2008